A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

Epidemiology, Correlation and Predictive Value of Disease Activity and Biomarkers in RA Patients Initiated on Infliximab in Clinical Practice

This 14-week non-interventional study will observe patients with rheumatoid arthritis (RA) who are being treated with infliximab for the first time, in order to learn about their disease characteristics. Patients in this study will be treated for RA with infliximab and in a usual manner as decided by their physician.

Inclusion Criteria:

• Subject has been diagnosed with RA
• Physician has decided, with the subject's consent, to begin treatment with infliximab
• Written informed consent form signed by both the subject and the physician.

Exclusion Criteria:

• Subjects who have previously been exposed to infliximab